We can't find the internet
Attempting to reconnect
18373.1 PFLS-LS
18373.1 PFLS-LS
Zusammenfassung
Optogenetic stimulation of glutamatergic transmission to study a new class of allosteric modulators in anxiety disorders and substance abuse
Weitere Texte
Abstract
The objective is to use an optogenetic approach to study the therapeutic potential of allosteric modulation of glutamatergic transmission (mGluR4 & 7) in the amygdala for the treatment of anxiety disorders and substance abuse. We will explore this in animal models of posttraumatic stress disorder and reward/motivation. We aim to improve efficacy and specificity of allosteric glutamatergic modulators by assessing their effects on stimulation of specific pathways related to these therapeutic areas.
Beteiligte
Tim Dyer
Wirtschaftspartner
Tim.Dyer@addexpharma.com
Addex Pharmaceuticals SA Tim Dyer Chemin des Aulx 12 1228 Plan-les-Ouates GE CH
Ron Stoop
Kontaktperson
rstoop@unil.ch
CHUV Centre Hospitalier Universitaire Va Ron Stoop Route de Cery 1008 Prilly VD CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2015-12-31
- Enddatum
- 2018-09-30
- Bewilligte Gesamtkosten
- CHF 666240.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T490 Biotechnology 100.0%